Lantern Pharma Inc. (LTRN)
Lantern Pharma Max Pain By Strike
LTRN trades at $4.39, 339.0% above the near-term max pain of $1 expiring Sep 19, 2025 (23 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$5), reflecting growing call interest at higher strikes. Key magnetic zone at 1 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Lantern Pharma Max Pain By Expiry
Max pain for LTRN shows an upward trend from 1 to 5, suggesting bullish positioning in longer-dated options. The 145% spread signals divergent expectations across timeframes. Most levels below 4.39 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 1 | -3.39 (-77.22%) |
| Oct 17, 2025 | 4 | -0.39 (-8.88%) |
| Jan 16, 2026 | 5 | 0.61 (13.90%) |
| Apr 17, 2026 | 1 | -3.39 (-77.22%) |